Choate Investment Advisors - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.

Quarter-by-quarter ownership
Choate Investment Advisors ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$353,310,000
+195.9%
51,428
+151.5%
0.03%
+225.0%
Q3 2015$119,416,000
-61.9%
20,448
-46.0%
0.01%
-55.6%
Q2 2015$313,210,000
-7.1%
37,873
-7.5%
0.02%
-5.3%
Q1 2015$337,247,000
-4.5%
40,928
-20.4%
0.02%
-9.5%
Q4 2014$353,310,00051,4280.02%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$80,313,00015.61%
Opaleye Management Inc. 1,310,000$8,188,0003.42%
Camber Capital Management LP 5,405,235$33,783,0002.18%
IRONWOOD INVESTMENT MANAGEMENT LLC 471,516$2,947,0001.22%
HighVista Strategies LLC 807,100$5,044,0000.94%
JS Capital Management LLC 630,000$3,938,0000.94%
1492 Capital Management LLC 202,500$1,266,0000.92%
Palo Alto Investors LP 2,257,217$14,108,0000.78%
Geduld E E 185,100$1,157,0000.72%
Elk Creek Partners, LLC 1,592,527$9,953,0000.71%
View complete list of ARIAD PHARMACEUTICALS INC shareholders